Erector Spinae Block vs Conventional Analgesia for Postoperative Analgesia in PCNL

NCT ID: NCT06935006

Last Updated: 2025-04-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-01

Study Completion Date

2026-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

50 adult patients scheduled for percutaneous nephrolithotomy in Sohag university hospitals will be devided in two groups one of them will receive Sonographic guided erector spinae plane block using 20 ml volume of bupivacaine 0.25 percent and the other will receive conventional analgesia of 0.1 mg/kg IV morphine

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Percutaneous Nephrolithotomy (PCNL)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Erector spinae plane block group

Group Type ACTIVE_COMPARATOR

Sonographic guided Erector spinae plane block

Intervention Type PROCEDURE

Ultrasound guided plane block using 20 ml of 0.25% bupivacaine at the level of transverse process of T8

Conventional analgesia group

Group Type ACTIVE_COMPARATOR

Intravenous opioid

Intervention Type DRUG

0.1 mg/kg morphine intravenous pre operative

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sonographic guided Erector spinae plane block

Ultrasound guided plane block using 20 ml of 0.25% bupivacaine at the level of transverse process of T8

Intervention Type PROCEDURE

Intravenous opioid

0.1 mg/kg morphine intravenous pre operative

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA 1 to ASA 2 18 to 60 years

Exclusion Criteria

* patient refusal Significant neurological , psychiatric or neuromascular disease Drug abuse Pregnant or lactating women Suspected coagulopathy Morbid obesity Known allergy to some medications Septicaemia and local infection at block site
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sohag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmed Mahmoud Azmy

Assistant lecturer of Anaethesia and intensive care unit

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ahmed Mahmoud Azmy, Assistant lecturer

Role: CONTACT

01004793896

Fawzy Abbas, Assistant professor

Role: CONTACT

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Soh-Med-22-06-35

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.